聚合酵素鏈鎖反應市場規模、佔有率、成長分析，按類型、產品、應用、指示 - 產業預測，2024-2031

2022年全球聚合酵素鏈鎖反應（PCR）市場規模為241.7億美元，在預測期（2024-2031年）複合年成長率為2.4%，較2023年的247.5億美元成長。 299.2 億。

近年來，全球聚合酵素鏈鎖反應（PCR）市場經歷了顯著成長，並且仍然是分子生物學和診斷領域的重要技術。 PCR 是一種用於擴增和分析 DNA 和 RNA 樣本的通用方法，在研究、臨床診斷、法醫學分析和生物技術等多個領域中發揮基礎作用。這種成長是由感染疾病發病率上升、對個性化藥物的需求、基因組研究的進步以及對快速、準確的診斷工具（尤其是針對 COVID-19 大流行）的迫切需求等因素推動的。該市場的特點是有許多主要企業提供廣泛的 PCR 設備、耗材和服務。傳統的 PCR 技術正在發展為更有效率和自動化的系統，例如即時PCR和數位 PCR，提供更快的結果和更高的靈敏度。此外，可攜式PCR 設備的開拓正在將市場擴展到現場護理環境。

目錄

介紹

• 這項研究的目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場危機與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價值鏈分析
• 價格分析
• Start-Ups分析
• 監管環境
• 專利分析
• 管道分析
• 成功的關鍵因素
• 市場吸引力指數
• 競爭程度
• 主要投資機會
• 生態系繪圖

按類型：聚合酵素鏈鎖反應(PCR) 市場

• 市場概況
• 標準PCR
• 即時PCR
• 數位PCR
• 其他

依產品：聚合酵素鏈鎖反應(PCR) 市場

• 市場概況
• 裝置
• 試劑/耗材
• 軟體和服務

按適應症分類的聚合酵素鏈鎖反應(PCR) 市場

• 市場概況
• 感染疾病
• 腫瘤學
• 遺傳疾病
• 其他

依應用分類：聚合酵素鏈鎖反應(PCR) 市場

• 市場概況
• 醫療保健
  • 臨床
  • 病理檢查
  • 腫瘤檢查
  • 驗血
  • 其他
  • 研究
  • 法醫學
  • 其他
• 非醫療的
  • 食品
  • 其他

按地區分類：聚合酵素鏈鎖反應(PCR) 市場規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Thermo Fisher Scientific, Inc.（USA）
• Roche Holdings AG（Switzerland）
• Bio-Rad Laboratories, Inc.（USA）
• QIAGEN NV（Netherlands）
• Agilent Technologies, Inc.（USA）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Becton, Dickinson and Company（USA）
• Danaher Corporation（USA）
• Promega Corporation（USA）
• Merck KGaA（Germany）
• Fluidigm Corporation（USA）
• Eppendorf AG（Germany）
• Takara Bio Inc.（Japan）
• Abbott Laboratories（USA）
• BioMerieux SA（France）
• PerkinElmer, Inc.（USA）
• BioFire Diagnostics, LLC（USA）
• Biosearch Technologies, Inc.（USA）
• GenMark Diagnostics, Inc.（USA）
• Enzo Biochem, Inc.（USA）
• Illumina, Inc.（USA）
• New England Biolabs, Inc.（USA）
• Quantabio（USA）
• LGC Limited（UK）
• Bioer Technology Co., Ltd.（China）

Global Polymerase Chain Reaction (PCR) Market size was valued at USD 24.17 billion in 2022 and is poised to grow from USD 24.75 billion in 2023 to USD 29.92 billion by 2031, growing at a CAGR of 2.4% during the forecast period (2024-2031).

In recent years, the global polymerase chain reaction (PCR) market has experienced remarkable growth and remains a crucial technology in molecular biology and diagnostics. PCR, a versatile method for amplifying and analyzing DNA and RNA samples, plays a fundamental role across various fields including research, clinical diagnostics, forensic analysis, and biotechnology. Driving this growth are factors such as the rising incidence of infectious diseases, the demand for personalized medicines, advancements in genomics research, and the urgent need for rapid and accurate diagnostic tools, especially in response to the COVID-19 pandemic. The market is characterized by numerous prominent players offering a wide array of PCR instruments, consumables, and services. Traditional PCR techniques are evolving towards more efficient and automated systems like real-time PCR and digital PCR, offering quicker results and enhanced sensitivity. Furthermore, the development of portable PCR devices has expanded the market's reach into point-of-care settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Polymerase Chain Reaction (PCR) Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Polymerase Chain Reaction (PCR) Market Segmental Analysis

The polymerase chain reaction (PCR) market is segmented based on type, product, indication, end user, and region. By type, the market is segmented into standard PCR, real-time PCR, digital PCR, and others. By product, the market is segmented into instruments, reagents & consumables, and software & services. By indication, the market is segmented into infectious diseases, oncology, genetic disorders, and others. By application, the market is segmented into medical and non-medical. Medical applications are further sub-segmented into clinical (pathology testing, oncology testing, blood screening, and others), research, forensics, and others. Non-medical applications are further sub-segmented into food, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Polymerase Chain Reaction (PCR) Market

PCR is widely employed in molecular diagnostics to detect and monitor various diseases, including infectious diseases, cancer, and genetic disorders. The increasing demand for accurate and swift diagnostic tools, especially amidst the COVID-19 pandemic, has bolstered the need for PCR-based comprehensive tests and diagnostics, a trend expected to continue propelling the PCR market forward.

Restraints in the Global Polymerase Chain Reaction (PCR) Market

The high expenses associated with PCR units and consumables pose a significant obstacle for smaller laboratories, clinics, and research facilities. This financial barrier hampers accessibility to PCR technology in resource-limited settings, potentially impeding market expansion, especially in developing areas.

Market Trends of the Global Polymerase Chain Reaction (PCR) Market

A remarkable trend within the PCR marketplace was the increasing popularity of point-of-care (POC) PCR testing solutions, fueled by the necessity for swift and on-site diagnostic testing, notably amid the COVID-19 pandemic. POC PCR testing presents the advantage of rapid results, proving crucial in scenarios where timely diagnosis is imperative, such as infectious disease outbreaks. As healthcare providers and clinics pursued quicker and more convenient testing options, POC PCR devices and kits gained momentum in the market.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Polymerase Chain Reaction (PCR) Market by Type

• Market Overview
• Standard PCR
• Real-time PCR
• Digital PCR
• Others

Polymerase Chain Reaction (PCR) Market by Product

• Market Overview
• Instruments
• Reagents & Consumables
• Software & Services

Polymerase Chain Reaction (PCR) Market by Indication

• Market Overview
• Infectious Diseases
• Oncology
• Genetic Disorders
• Others

Polymerase Chain Reaction (PCR) Market by Application

• Market Overview
• Medical
  • Clinical
  • Pathology Testing
  • Oncology Testing
  • Blood Screening
  • Others
  • Research
  • Forensics
  • Others
• Non-Medical
  • Food
  • Others

Polymerase Chain Reaction (PCR) Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holdings AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioFire Diagnostics, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosearch Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Biochem, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quantabio (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioer Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments